Rapport Therapeutics
(NASDAQ) RAPP
Rapport Therapeutics Financials at a Glance
Market Cap
$1.93B
Revenue (TTM)
$20.00M
Net Income (TTM)
-$107.28M
EPS (TTM)
-$2.60
P/E Ratio
-15.52
Dividend
$0.00
Beta (Volatility)
1.43 (Average)
Dividend
$0.00
Beta (Volatility)
1.43 (Average)
Price
$40.48
Volume
436,134.109
Open
$40.06
Price
$40.48
Volume
436,134.109
Open
$40.06
Previous Close
$40.39
Daily Range
$39.37 - $40.91
52-Week Range
$11.05 - $42.27
Estimated Earnings Date
Aug 6, 2026
Dividend
$0.00
Beta (Volatility)
1.43 (Average)
Price
$40.48
Volume
436,134.109
Open
$40.06
Previous Close
$40.39
Daily Range
$39.37 - $40.91
52-Week Range
$11.05 - $42.27
Estimated Earnings Date
Aug 6, 2026
RAPP News
RAPP: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Rapport Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
84
CEO
Abraham N. Ceesay, MBA
Website
www.rapportrx.comHeadquarters
Boston, DE, US
RAPP Financials
Key Financial Metrics (TTM)
Gross Margin
96.26%
Operating Margin
-611.03%
Net Income Margin
-536.38%
Return on Equity
-24.79%
Return on Capital
-25.21%
Return on Assets
-21.56%
Earnings Yield
-6.44%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.93B
Shares Outstanding
47.83M
Volume
436.13K
Avg. Volume
353.98K
Financials (TTM)
Gross Profit
$19.25M
Operating Income
-$122.21M
EBITDA
-$118.15M
Operating Cash Flow
-$80.30M
Capital Expenditure
-$411.00K
Free Cash Flow
-$80.71M
Cash & ST Invst.
$476.78M
Total Debt
$10.80M
Rapport Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$20.00M
N/A
Gross Profit
$19.77M
+8203.7%
Gross Margin
98.87%
N/A
Market Cap
$1.93B
N/A
Market Cap/Employee
$28.00M
N/A
Employees
69
N/A
Net Income
-$19.86M
+17.5%
EBITDA
-$23.99M
+10.7%
Quarterly Fundamentals
Total Cash
$476.78M
+67.1%
Total Debt
$10.80M
+37.8%
Accounts Receivable
$58.00K
N/A
Inventory
$0.00
N/A
Long Term Debt
$8.19M
+19.8%
Short Term Debt
$2.62M
+159.4%
Return on Assets
-21.56%
N/A
Return on Invested Capital
-25.48%
N/A
Free Cash Flow
-$13.15M
+36.0%
Operating Cash Flow
-$13.06M
+35.5%